Sanofi SA (SASY.PA)

SASY.PA on Paris Stock Exchange

97.33EUR
11:35am EDT
Change (% chg)

€1.47 (+1.53%)
Prev Close
€95.86
Open
€95.74
Day's High
€97.67
Day's Low
€94.32
Volume
2,829,637
Avg. Vol
3,113,696
52-wk High
€99.23
52-wk Low
€69.58

SASY.PA

Chart for SASY.PA

About

Sanofi, formerly Sanofi-Aventis is a global and diversified healthcare company. The Company discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi focuses on the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, rare diseases, consumer... (more)

Overall

Beta: 0.63
Market Cap(Mil.): €127,111.30
Shares Outstanding(Mil.): 1,326.24
Dividend: 2.85
Yield (%): 2.97

Financials

  SASY.PA Industry Sector
P/E (TTM): 29.22 41.06 41.71
EPS (TTM): 3.28 -- --
ROI: 5.49 16.86 16.20
ROE: 7.77 17.36 17.00
Search Stocks

BRIEF-Ypsomed to increase production capacity for new project with Sanofi

* Long-standing partnership between the French pharmaceutical group Sanofi and the Ypsomed Group will be bolstered by new major project

24 Apr 2015

BRIEF-Sanofi to present new data from Lemtrada clinical development

* Says effect of Genzyme's multiple sclerosis treatment Lemtrada (alemtuzumab) on slowing brain atrophy and MRI lesion activity has been maintained through four years

23 Apr 2015

BRIEF-Innate Pharma and Sanofi collaborate on antibody-drug conjugates

* Innate Pharma and Sanofi SA collaborate on next generation antibody-drug conjugates

16 Apr 2015

BRIEF-Delta Plus Group acquires 50 pct of North American Elvex

* Announces the signing of a strategic partnership on the North American market with Elvex

08 Apr 2015

BRIEF-Schrödinger signs $120 million deal with Sanofi - Schrödinger

* Announced a collaboration agreement with Sanofi of $120 million

02 Apr 2015

Sanofi chairman says acquisitions not 'indispensable' for future

PARIS - French pharmaceutical company Sanofi has examined acquisitions opportunities but does not view deal-making as "indispensable" to its future, its chairman told French paper Les Echos in an interview.

30 Mar 2015

Sanofi chairman says acquisitions not 'indispensable' for future

PARIS, March 30 - French pharmaceutical company Sanofi has examined acquisitions opportunities but does not view deal-making as "indispensable" to its future, its chairman told French paper Les Echos in an interview.

30 Mar 2015

Sanofi to launch Toujeo diabetes drug in U.S. on Monday: source

PARIS - French drugmaker Sanofi plans to launch its new Toujeo insulin for diabetics in the United States on Monday, according to a source familiar with the matter.

27 Mar 2015

Sanofi to launch Toujeo diabetes drug in U.S. on Monday -source

PARIS, March 27 - French drugmaker Sanofi plans to launch its new Toujeo insulin for diabetics in the United States on Monday, according to a source familiar with the matter.

27 Mar 2015

BRIEF-Sanofi Pasteur's Gardasil 9 HPV vaccine gets positive opinion from EMA

* Says Gardasil 9, new HPV vaccine from Sanofi Pasteur MSD granted positive opinion by European Ccommittee for Medicinal Products for Human Use

27 Mar 2015

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: ValuEngine, Inc.
$49.00
Provider: S&P Capital IQ – STARS Reports
$127.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks